Standout Papers
Citation Impact
Citing Papers
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
2010 StandoutScience
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
α2‐Macroglobulin reduces paracrine‐ and autocrine‐stimulated matrix synthesis of cultured rat hepatic stellate cells
1999
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Liver fibrosis
2005 Standout
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1999 Standout
Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer’s Disease
1999
Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies
2002
Vascular dementia
2015 Standout
The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis
2000
Differential validity of psychometric tests in dementia of the Alzheimer type
1992
Estrogen blocks inducible nitric oxide synthase accumulation in LPS-activated microglia cells
2000
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Alzheimer's disease
2011 Standout
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Function and Regulation of CREB Family Transcription Factors in the Nervous System
2002 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Design of a Phosphinate‐Based Fluorescent Probe for Superoxide Detection in Mouse Peritoneal Macrophages
2006
Sites of erythropoietin production
1997 StandoutNobel
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity
2001
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies
2012
Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues
2006 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
A Phosphinate‐Based Red Fluorescent Probe for Imaging the Superoxide Radical Anion Generated by RAW264.7 Macrophages
2007
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study
2009
Non-Cholinergic Strategies for Treating and Preventing Alzheimer??s Disease
2002
Mental and Behavioral Disturbances in Dementia: Findings From the Cache County Study on Memory in Aging
2000
The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials
2004
The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver
1992
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
2016 Standout
Comparison of the Alzheimer’s Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in Differentiating Elderly Individuals with Different Degrees of White Matter Changes
2007
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Estrogen Modulates Neuronal Bcl‐xl Expression and β‐Amyloid‐Induced Apoptosis
1999
Is anti-cholinesterase therapy of Alzheimer’s disease delaying progression?
2001
ADAMs family members as amyloid precursor protein α‐secretases
2003
Production and Actions of Estrogens
2002 Standout
Alzheimer's Disease
2004 Standout
Neurodegenerative diseases and oxidative stress
2004 Standout
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Herbal Medicines and Perioperative Care
2001 Standout
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Mild cognitive impairment as a diagnostic entity
2004 Standout
Roles of TGF-beta in hepatic fibrosis
2002
Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years
2005
Cholinesterase Inhibitors for Alzheimer??s Disease
2001
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
<emph type="ital">Ginkgo biloba</emph> for Preventing Cognitive Decline in Older Adults<subtitle>A Randomized Trial</subtitle>
2009
Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration
2006 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
The Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>
2002
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Treatment of the Neuropsychiatric Symptoms in Alzheimer's Disease
2003
Invited Review Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications
1998
Exercise and Physical Activity for Older Adults
2009 Standout
Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer’s disease
1999
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
1993 Standout
Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory
2000 Standout
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo.
1994
Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells
1994 StandoutNobel
AMPA potentiator treatment of cognitive deficits in Alzheimer disease
2007
Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer’s disease
2000
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
2011
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
1997
Physical Activity and Public Health in Older Adults
2007 Standout
Galantamine in AD
2000
A 5-month, randomized, placebo-controlled trial of galantamine in AD
2000
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.
2002
Efficient Total Synthesis of Novel Bioactive Microbial Metabolites
2008 StandoutNobel
Prostaglandin F2α and D2 Release From Primary Ito Cell Cultures After Stimulation With Noradrenaline and Atp But Not Adenosine
1994
A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer’s disease
1999
Nonreciprocal homeostatic compensation in Drosophila potassium channel mutants
2017 StandoutNobel
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Estrogen for Alzheimer’s disease in women
2000
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Works of Florian Bieber being referenced
Dexamethasone modulates α2-macroglobulin and apolipoprotein E gene expression in cultured rat liver fat-storing (Ito) cells
1991
The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease
2001
The Bayer-Activities of Daily Living Scale (B-ADL): Results from a Validation Study in Three European Countries
2001
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Metrifonate in Patients with Probable Alzheimer Disease
2000
The Alzheimer's disease assessment scale
1997
4-42-05 Metrifonate: Potential therapy for Alzheimer's disease
1997
Nimodipine in the Treatment of Probable Alzheimerʼs Disease
1996
Metrifonate treatment of the cognitive deficits of Alzheimer's disease
1998
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease
1998